|Videos|May 30, 2023
CAR-T Cell Therapies Entering the Mainstream of Cancer Clinical Trials & Treatment
Author(s)Medidata
KEY LEARNING OBJECTIVES
- Audience will have an understanding how Medidata can have an impact with Clinical Trial pharma and bio tech firms that are working in this therapeutic area
- What are the challenges that CAR-T developers face and how can data help address those challenges
- How is Medidata AI “data” different from other data providers
Related Content
Trending on Applied Clinical Trials Online
1
When the Slack Runs Out: AI and the CRO Operating Model
2
Why Payment Performance Has Become a Competitive Differentiator for Sponsors
3
Speed, Discipline, and the New Rules of Biotech Development: Q&A with Stella K. Vnook, PhD, Kaida BioPharma and Aviva Ventures
4
ACT Brief: AI Literacy and Ecosystem Adoption Requirements, CRO Operating Models Under Agentic AI Pressure, and Platform Collaborations in Vaccine and Antibody Discovery
5